|
U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH NIH News Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) <https://www.nichd.nih.gov/>
For Immediate Release: Thursday, November 10, 2022 CONTACT: Linda Huynh or Robert Bock, 301-496-5133, <e-mail:nichdpress@xxxxxxxxxxxx> MEDIA AVAILABILITY NIH-FUNDED RESEARCHERS TO BEGIN STUDY OF INTRAVENOUS IRON TREATMENT FOR POST-PREGNANCY ANEMIA
Study to enroll participants in seven low- and middle-income countries WHAT: Researchers supported by the National Institutes of Health are launching a large study to evaluate a single dose of intravenous iron to treat women experiencing anemia after giving birth. The study will enroll nearly 5,000 women in Bangladesh,
India, Pakistan, the Democratic Republic of Congo, Kenya, Zambia and Guatemala. It will be conducted by researchers in the Global Network for Women’s and Children’s Health, a group of clinical sites funded by NIH’s Eunice Kennedy Shriver National Institute
of Child Health and Human Development (NICHD). The Foundation for the National Institutes of Health <https://www.fnih.org/> is providing more than $6 million in funding for the study, with contributions from a grant from the Bill and Melinda Gates Foundation. Participants will be randomized to receive either a single dose of intravenous iron solution between six- and 48-hours after giving birth or a six-week supply of oral iron supplements. According to the standard of care, both groups also
will receive the vitamin folate in the infusion or as tablets. Iron deficiency anemia increases sharply among individuals after birth, resulting in fatigue, weakness, shortness of breath, reduced cognitive abilities, depression and other symptoms. Anemia may also compromise a mother’s ability to provide
care for her baby. Previous studies have found intravenous iron to be effective at preventing anemia in pregnancy, but it has not been studied as a treatment for anemia after pregnancy. Researchers will compare the prevalence of mild anemia, iron levels,
depression scores, quality of life scores and other measures between the two groups to assess the treatment’s effectiveness.
WHO: Marion Koso-Thomas, M.D., M.P.H., Medical Officer, NICHD Global Network for Women’s and Children’s Health, is available for comment. REFERENCE: Prevention of Iron Deficiency Anemia Post-delivery (PRIORITY). NICHD Global Network for Women’s and Children’s Health. <https://clinicaltrials.gov/ct2/show/NCT05590260>. ### About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD leads research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents,
and optimize abilities for all. For more information, visit https://www.nichd.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting
and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <https://www.nih.gov>. NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office ### This NIH News Release is available online at: <https://www.nih.gov/news-events/news-releases/nih-funded-researchers-begin-study-intravenous-iron-treatment-post-pregnancy-anemia> To subscribe (or unsubscribe) from NIH News Release mailings, go to <http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>. If you subscribed via the NIH LISTSERV, go to <https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>. |
